Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
CTEV
HOLDClaritev Corporation · Healthcare · United States · $368M · Avg Vol: $4M/d
60
StockRankGet insider-trade alerts
Q
41
V
57
M
57
P/E (TTM)
—
ROE
—
D/E
—
Dividend %
—
COMPANY DESCRIPTION
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.1B | 961.5M | 930.6M | 965.4M | -3.7% | 994.7M | 1.0B | 1.1B | 4.5% |
| EPS | -36.00 | -5.69 | -101.92 | -17.30 | — | -17.00 | — | — | — |
| Shares | 16.0M | 16.2M | 16.2M | 16.6M | +3.6% | 17.0M | — | — | — |
| Debt | 4.8B | 4.6B | 4.5B | 4.6B | -1.2% | 4.7B | — | — | — |
| Equity | 1.8B | 1.7B | 84.0M | -173.9M | -78.3% | — | — | — | — |
| Op CF | 372.4M | 171.7M | 107.6M | 117.3M | -32.0% | 133.0M | — | — | — |
| Inv CF | -104.4M | -249.8M | -118.1M | -121.0M | — | — | — | — | — |
| Fin CF | -115.7M | -181.0M | -41.3M | 2.4M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+0.7%
SMA 50SMA 200
Close
$34.07
RSI (14)
62.3
52W High
$74.07
From 52W High
0.5%
SCORE BREAKDOWN
Quality
41
ROIC
0.7%47.3
ROE
—N/A
GP/Assets
14.8%36.0
Op. Margin
12.8%71.1
FCF/Assets
2.1%56.0
Piotroski
549.9
Int. Cover
0.1x37.6
D/E Ratio
—N/A
Current Ratio
0.99x11.2
Value
57
P/E (TTM)
—N/A
EV/EBITDA
9.8x71.0
P/FCF
3.6x92.2
P/B
-2.0x25.0
P/S
0.6x90.9
Div Yield
—N/A
Momentum
57
52W High %
46%18.6
RS 6M
19%82.4
SMA 50/200
0.94x51.6
EPS Rev 4W
+7.2%90.4
EPS Rev 12W
—N/A
EPS Improve
+143%82.7
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$368M
P/E (Forward)
4.6x
Gross Margin
73.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CTEV are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CTEV | Claritev Corporation(you) | $368M | 60 | HOLD |
| MDRX | Veradigm Inc. | $517M | 59 | HOLD |
| NRC | NRC Health | $474M | 72 | BUY |
| WEAV | Weave Communications, Inc. | $491M | 47 | HOLD |
| NURS.V | Hydreight Technologies Inc. | $167M | 57 | HOLD |
| TALK | Talkspace, Inc. | $873M | 63 | HOLD |
| SLP | Simulations Plus, Inc. | $371M | 80 | STRONG BUY |
| PHR | Phreesia, Inc. | $632M | 47 | HOLD |
| CARL | Carlsmed, Inc. | $294M | 38 | HOLD |
| EVH | Evolent Health, Inc. | $475M | 37 | HOLD |
Peer medians: ROE -25.6% · P/E 30.1x · Gross margin 55.7%